| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976493 | Brachytherapy | 2015 | 6 Pages |
Abstract
Reirradiation with ISBT is both safe and effective. In patients with recurrent cancer, urethra D0.1cc predicts for increased urinary toxicity. Increased tumor size is a negative prognostic factor in patients receiving ISBT for cancer recurrence.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mark J. Amsbaugh, Neal Bhatt, Thomas Hunter, Jeremy Gaskins, Lynn Parker, Daniel Metzinger, Ashley Amsbaugh, Keith Sowards, Moataz El-Ghamry,